KDL Biotech Ltd (KDL) is a publicly held healthcare company, engaged in the development of various healthcare products including diagnostics and therapeutic products, active pharmaceutical ingredients and finished dosage forms. The company has extended its health care portfolio in the fields of bio-technology, sophisticated medical electronic equipments and produces Semi Synthetic Penicillin (SSP) on a large scale. KDL operates in about 50 countries providing contract manufacturing and brand marketing services in various product areas like cardiovascular, gastrointestinal and diabetic range, antibiotics, pain management, respiratory range. KDL has a wide distribution and marketing network in 15 countries including Europe and South Africa. KDL Biotech is headquartered at Mumbai in Maharashtra, India.